0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In Vitro Fertilization Market - Drivers, Restraints Opportunities, Trends, and Forecast up to 2024
Published Date: April 2019
|
Report Code: INFO-Othe-333
Home | Category |Health |Reproductive Health
Global In Vitro Fertilization Market

Global In Vitro Fertilization Market - Drivers, Restraints Opportunities, Trends, and Forecast up to 2024

Code: INFO-Othe-333
Report
April 2019
83 Pages
Infoholic Research
Region: Global,
Description
Table of Content
Tables & Figures

Global In Vitro Fertilization Market – Drivers, Restraints Opportunities, Trends, and Forecast up to 2024
Overview:
In Vitro Fertilization (IVF) is a process of fertilization that takes place outside the body, i.e., in vitro. IVF involves the production of eggs, i.e., superovulation, in women by medication and injecting hormones. The matured eggs are removed from ovary using oocyte aspiration systems, fertilized with the sperm of the donor, grown in a laboratory till it gets developed, and finally, the resulting embryo is implanted into the uterus. In recent years, PGD techniques are being used to screen the embryo for possible risk of passing on genetic disorders to offspring because one or both the partners may be carriers for a genetic disease. IVF also helps in maximizing the chance of conceiving in patients with a low ovarian reserve.
The in vitro fertilization market is driven by increasing awareness among the public about fertility and accessible treatment options, delayed pregnancies, reducing fertility rates, and initiation from the government to promote IVF treatment. However, high treatment cost, ethical concerns related to IVF, and low success rate of the procedure may slow down the growth of the in vitro fertilization market.
Market Analysis: The “global in vitro fertilization market” is estimated to witness a CAGR of 11.2% during the forecast period 2018–2024. The global market is analyzed based on four segments – products, cycle types, end-users, and regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). Europe is the major shareholder in the global in vitro fertilization market, followed by North America. Increasing demand for assisted reproductive technology procedures and smooth implementation of advanced technology make Europe a dominant shareholder in the market. Whereas, Asia Pacific is the fastest growing market due to increasing fertility tourism, upsurge in awareness, and acceptance of the technology.

Product Analysis: The in vitro fertilization market, by products, is segmented into reagents and instruments. Reagents include embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Instruments comprise imaging system, sperm separation system, ovum aspiration pump, micromanipulator system, incubators, cryosystems, and others. The instruments segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period.

Cycle Type Analysis: The in vitro fertilization market, by cycle type, is segmented into fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor IVF cycles. Fresh IVF cycles segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period due to the increased success rate in the first attempt.

End-users Analysis: The in vitro fertilization market, by end-users, is segmented into hospitals and research laboratories, fertility and surgical centers, and cryobanks. Fertility and surgical centers segment occupied a significant market share in 2017 and is expected to remain the same for the next five years due to the availability of technologically advanced IVF treatment and a broad range of fertility treatment with reimbursement facilities.

Key Players:
Thermo Fisher Scientific, Inc., Vitrolife, Cook Medical Inc., Cooper Companies (CopperSurgical Inc.), Irvine Scientific, Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno, Inc., ESCO Micro Pte Ltd., and niche players.

Competitive Analysis:
There is an increase in acquisition, collaboration between IVF-related companies, and launching of new IVF products due to the favorable environment for IVF across the globe. For instance, in August 2018, Ferring Pharmaceuticals and Celmatix announced a collaboration, and the primary goal is to uncover new insights into ovarian biology and to accelerate the development of personalized interventions in women health and reproductive medicine. In August 2018, Thomson Medical announced to extend IVF services to China, in collaboration with assisted reproduction specialist IVI-RMA.

Benefits: The report provides complete details about the products offered by in vitro fertilization companies in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.


Table of Contents


1 INDUSTRY OUTLOOK 8
1.1 Industry overview 8
2 Report Outline 9
2.1 Report Scope 9
2.2 Report Summary 9
2.3 Research Methodology 10
2.4 Report Assumptions 11
3 Market Snapshot 12
3.1 Market Definition – Infoholic Research 12
3.2 Advantages of in vitro fertilization 12
3.3 Disadvantage of in vitro fertilization 12
3.4 Need of in vitro fertilization 12
3.5 Process of in vitro fertilization 13
3.6 Segmented Addressable Market (SAM) 13
3.7 Trends of the in vitro fertilization market 14
3.8 Related Markets 15
3.8.1 Female Condom market 15
3.8.2 Erectile dysfunction market 15
4 Market Outlook 16
4.1 History of In Vitro Fertilization 16
4.2 Market segmentation 16
4.3 PEST Analysis 17
4.4 Porter 5(Five) Forces 18
5 Market Characteristics 20
5.1 DRO – Global In Vitro Fertilization Market Dynamics 20
5.1.1 Drivers 20
5.1.1.1 Reducing fertility rates 20
5.1.1.2 Deferred pregnancies among women 21
5.1.2 Opportunities 21
5.1.2.1 Initiation from the government to promote IVF treatment 21
5.1.2.2 Increased fertility tourism 21
5.1.3 Restraints 22
5.1.3.1 High cost of IVF treatment 22
5.1.3.2 Low success rate of IVF treatment 22
5.2 DRO – Impact Analysis 22
5.3 Key Stakeholders 23
6 Products: Market Size and Analysis 25
6.1 Overview 25
6.2 By reagents 26
6.2.1 Cryopreservation media 27
6.2.2 Sperm processing media 28
6.2.3 Embryo culture media 28
6.2.4 Ovum processing media 29
6.3 By Instruments 29
6.3.1 Imaging system 30
6.3.2 Ovum aspiration pumps 31
6.3.3 Sperm separation systems 31
6.3.4 Micromanipulator systems 31
6.3.5 Incubators 32
6.3.6 Cryosystems 32
6.3.7 Others 32
7 By Cycle type: Market Size and Analysis 33
7.1 Overview 33
7.2 Fresh IVF cycle (Non-Donor) 34
7.3 Thawed IVF cycle (Non-donor) 35
7.4 Donor egg IVF cycles 36
8 By End-Users: Market Size and Analysis 38
8.1 Overview 38
8.2 Hospitals and research laboratories 39
8.3 Fertility and surgical centers 39
8.4 Cryobanks 39
9 Regions: Market Size and Analysis 40
9.1 Overview 40
9.2 North America 41
9.3 Europe 43
9.4 Asia Pacific 44
9.5 Rest of the World 45
10 Competitive Landscape 47
10.1 Overview 47
11 Vendor Profiles 50
11.1 Thermo Fisher Scientific, Inc. 50
11.1.1 Overview 50
11.1.2 Business Units 54
11.1.3 Geographic Presence 55
11.1.4 Business focus 56
11.1.5 SWOT analysis 57
11.1.6 Business Strategy 57
11.2 Vitrolife 58
11.2.1 Overview 58
11.2.2 Geographic Presence 61
11.2.3 Business Focus 62
11.2.4 SWOT Analysis 63
11.2.5 Business Strategies 63
11.3 Cook Medical Inc. 64
11.3.1 Overview 64
11.3.2 Business Focus 66
11.3.3 SWOT Analysis 66
11.3.4 Business Strategies 66
11.4 Cooper Companies (CooperSurgical Inc.) 67
11.4.1 Overview 67
11.4.2 Business Unit 69
11.4.3 Geographic Presence 70
11.4.4 Business Focus 70
11.4.5 SWOT Analysis 71
11.4.6 Business Strategy 71
11.5 Irvine Scientific 72
11.5.1 Overview 72
11.5.2 Business Focus 74
11.5.3 SWOT Analysis 74
11.5.4 Business Strategy 75
12 Companies to Watch For 76
12.1 Genea Limited 76
12.1.1 Overview 76
12.2 EMD Sereno, Inc. 77
12.2.1 Overview 77
12.3 ESCO Micro Pte Ltd 78
12.3.1 Overview 78
12.3.2 ESCO Micro Pte Ltd: Recent Developments 79
12.4 Hunter Scientific 79
12.4.1 Overview 79
12.5 OvaScience Inc 80
12.5.1 Overview 80
12.5.2 OvaScience Inc: Recent Developments 80
12.6 Oxford Gene Technology 81
12.6.1 Overview 81
12.6.2 Oxford Gene Technology: Recent Developments 81
13 Annexure 82
13.1 Abbreviations 82

List of Tables


TABLE 1 GLOBAL IN VITRO FERTILIZATION MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION) 41
TABLE 2 OTHER PROMINENT VENDORS OF IN VITRO FERTILIZATION MARKET 48
TABLE 3 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 50
TABLE 4 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 51
TABLE 5 VITROLIFE: OFFERINGS 58
TABLE 6 VITROLIFE: RECENT DEVELOPMENTS 60
TABLE 7 COOK MEDICAL INC.: PRODUCT OFFERINGS 64
TABLE 8 COOK MEDICAL INC: RECENT DEVELOPMENTS 65
TABLE 9 COOPER COMPANIES (COOPERSURGICAL INC.): OFFERINGS 67
TABLE 10 COOPER COMPANIES (COOPERSURGICAL INC): RECENT DEVELOPMENTS 68
TABLE 11 IRVINE SCIENTIFIC: PRODUCT OFFERINGS 72
TABLE 12 IRVINE SCIENTIFIC: RECENT DEVELOPMENTS 74
TABLE 13 GENEA LIMITED: SNAPSHOT 76
TABLE 14 GENEA LIMITED: RECENT DEVELOPMENTS 76
TABLE 15 EMD SERENO, INC.: SNAPSHOT 77
TABLE 16 EMD SERENO, INC.: RECENT DEVELOPMENTS 77
TABLE 17 ESCO MICRO PTE LTD: SNAPSHOT 78
TABLE 18 HUNTER SCIENTIFIC: SNAPSHOT 79
TABLE 19 OVASCIENCE: SNAPSHOT 80
TABLE 20 OXFORD GENE TECHNOLOGY: SNAPSHOT 81

List of  Charts


CHART 1 RESEARCH METHODOLOGY OF GLOBAL IN VITRO FERTLIZATION MARKET 10
CHART 2 GLOBAL IN VITRO FERTILIZATION MARKET REVENUE, 2017–2024 ($MILLION) 14
CHART 3 SEGMENTATION OF GLOBAL IN VITRO FERTILIZATION MARKET 16
CHART 4 PEST ANALYSIS OF GLOBAL IN VITRO FERTILIZATION MARKET 17
CHART 5 PORTER 5 FORCES ON GLOBAL IN VITRO FERTILIZATION MARKET 18
CHART 6 DRO – IMPACT ANALYSIS OF GLOBAL IN VITRO FERTILIZATION MARKET 22
CHART 7 KEY STAKEHOLDERS 23
CHART 8 GLOBAL IN VITRO FERTILIZATION MARKET BY PRODUCT SEGMENTATION, 2017 (%) 25
CHART 9 GLOBAL IN VITRO FERTILIZATION MARKET BY PRODUCT SEGMENTATION, 2024 (%) 25
CHART 10 GLOBAL REAGENTS MARKET FORECAST, 2017–2024 ($MILLION) 26
CHART 11 GLOBAL REAGENTS MARKET SHARE, BY TYPE, 2017 (%) 27
CHART 12 GLOBAL INSTRUMENTS MARKET FORECAST, 2017–2024 ($MILLION) 29
CHART 13 GLOBAL INSTRUMENTS MARKET SHARE, BY TYPE, 2017 (%) 30
CHART 14 GLOBAL IN VITRO FERTILIZATION MARKET BY CYCLE TYPE SEGMENTATION, 2017 (%) 33
CHART 15 GLOBAL IN VITRO FERTILIZATION MARKET BY CYCLE TYPE SEGMENTATION, 2024 (%) 33
CHART 16 GLOBAL FRESH IVF CYCLE MARKET FORECAST, 2017–2024 ($MILLION) 34
CHART 17 GLOBAL THAWED IVF CYCLE MARKET FORECAST, 2017–2024 ($MILLION) 36
CHART 18 GLOBAL DONOR EGG IVF CYCLES MARKET FORECAST, 2017–2024 ($MILLION) 37
CHART 19 GLOBAL IN VITRO FERTILIZATION MARKET BY END USERS SEGMENTATION, 2017 (%) 38
CHART 20 GLOBAL IN VITRO FERTILIZATION MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 40
CHART 21 GLOBAL IN VITRO FERTILIZATION MARKET BY GEOGRAPHICAL SEGMENTATION, 2024 (%) 41
CHART 22 IN VITRO FERTILIZATION MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION) 42
CHART 23 IN VITRO FERTILIZATION MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION) 43
CHART 24 IN VITRO FERTILIZATION MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION) 45
CHART 25 IN VITRO FERTILIZATION MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION) 46
CHART 26 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT 54
CHART 27 THERMO FISHER SCIENTIFIC INC: BUSINESS UNITS 54
CHART 28 THERMO FISHER SCIENTIFIC, INC.: GEOGRAPHIC PRESENCE 55
CHART 29 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS 57
CHART 30 VITROLIFE: OVERVIEW SNAPSHOT 60
CHART 31 VITROLIFE: GEOGRAPHIC PRESENCE 61
CHART 32 : SWOT ANALYSIS 63
CHART 33 COOK MEDICAL INC.: SWOT ANALYSIS 66
CHART 34 COOPER COMPANIES (COOPERSURGICAL INC.): OVERVIEW SNAPSHOT 68
CHART 35 COOPER COMPANIES (COOPERSURGICAL INC.): BUSINESS UNITS 69
CHART 36 COOPER COMPANIES (COOPERSURGICAL INC.): GEOGRAPHIC PRESENCE 70
CHART 37 COOPER COMPANIES (COOPERSURGICAL INC.): SWOT ANALYSIS 71
CHART 38 IRVINE SCIENTIFIC: SWOT ANALYSIS 74

Global In Vitro Fertilization Market – Drivers, Restraints Opportunities, Trends, and Forecast up to 2024
Overview:
In Vitro Fertilization (IVF) is a process of fertilization that takes place outside the body, i.e., in vitro. IVF involves the production of eggs, i.e., superovulation, in women by medication and injecting hormones. The matured eggs are removed from ovary using oocyte aspiration systems, fertilized with the sperm of the donor, grown in a laboratory till it gets developed, and finally, the resulting embryo is implanted into the uterus. In recent years, PGD techniques are being used to screen the embryo for possible risk of passing on genetic disorders to offspring because one or both the partners may be carriers for a genetic disease. IVF also helps in maximizing the chance of conceiving in patients with a low ovarian reserve.
The in vitro fertilization market is driven by increasing awareness among the public about fertility and accessible treatment options, delayed pregnancies, reducing fertility rates, and initiation from the government to promote IVF treatment. However, high treatment cost, ethical concerns related to IVF, and low success rate of the procedure may slow down the growth of the in vitro fertilization market.
Market Analysis: The “global in vitro fertilization market” is estimated to witness a CAGR of 11.2% during the forecast period 2018–2024. The global market is analyzed based on four segments – products, cycle types, end-users, and regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). Europe is the major shareholder in the global in vitro fertilization market, followed by North America. Increasing demand for assisted reproductive technology procedures and smooth implementation of advanced technology make Europe a dominant shareholder in the market. Whereas, Asia Pacific is the fastest growing market due to increasing fertility tourism, upsurge in awareness, and acceptance of the technology.

Product Analysis: The in vitro fertilization market, by products, is segmented into reagents and instruments. Reagents include embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Instruments comprise imaging system, sperm separation system, ovum aspiration pump, micromanipulator system, incubators, cryosystems, and others. The instruments segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period.

Cycle Type Analysis: The in vitro fertilization market, by cycle type, is segmented into fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor IVF cycles. Fresh IVF cycles segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period due to the increased success rate in the first attempt.

End-users Analysis: The in vitro fertilization market, by end-users, is segmented into hospitals and research laboratories, fertility and surgical centers, and cryobanks. Fertility and surgical centers segment occupied a significant market share in 2017 and is expected to remain the same for the next five years due to the availability of technologically advanced IVF treatment and a broad range of fertility treatment with reimbursement facilities.

Key Players:
Thermo Fisher Scientific, Inc., Vitrolife, Cook Medical Inc., Cooper Companies (CopperSurgical Inc.), Irvine Scientific, Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno, Inc., ESCO Micro Pte Ltd., and niche players.

Competitive Analysis:
There is an increase in acquisition, collaboration between IVF-related companies, and launching of new IVF products due to the favorable environment for IVF across the globe. For instance, in August 2018, Ferring Pharmaceuticals and Celmatix announced a collaboration, and the primary goal is to uncover new insights into ovarian biology and to accelerate the development of personalized interventions in women health and reproductive medicine. In August 2018, Thomson Medical announced to extend IVF services to China, in collaboration with assisted reproduction specialist IVI-RMA.

Benefits: The report provides complete details about the products offered by in vitro fertilization companies in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.


Read More

Table of Contents


1 INDUSTRY OUTLOOK 8
1.1 Industry overview 8
2 Report Outline 9
2.1 Report Scope 9
2.2 Report Summary 9
2.3 Research Methodology 10
2.4 Report Assumptions 11
3 Market Snapshot 12
3.1 Market Definition – Infoholic Research 12
3.2 Advantages of in vitro fertilization 12
3.3 Disadvantage of in vitro fertilization 12
3.4 Need of in vitro fertilization 12
3.5 Process of in vitro fertilization 13
3.6 Segmented Addressable Market (SAM) 13
3.7 Trends of the in vitro fertilization market 14
3.8 Related Markets 15
3.8.1 Female Condom market 15
3.8.2 Erectile dysfunction market 15
4 Market Outlook 16
4.1 History of In Vitro Fertilization 16
4.2 Market segmentation 16
4.3 PEST Analysis 17
4.4 Porter 5(Five) Forces 18
5 Market Characteristics 20
5.1 DRO – Global In Vitro Fertilization Market Dynamics 20
5.1.1 Drivers 20
5.1.1.1 Reducing fertility rates 20
5.1.1.2 Deferred pregnancies among women 21
5.1.2 Opportunities 21
5.1.2.1 Initiation from the government to promote IVF treatment 21
5.1.2.2 Increased fertility tourism 21
5.1.3 Restraints 22
5.1.3.1 High cost of IVF treatment 22
5.1.3.2 Low success rate of IVF treatment 22
5.2 DRO – Impact Analysis 22
5.3 Key Stakeholders 23
6 Products: Market Size and Analysis 25
6.1 Overview 25
6.2 By reagents 26
6.2.1 Cryopreservation media 27
6.2.2 Sperm processing media 28
6.2.3 Embryo culture media 28
6.2.4 Ovum processing media 29
6.3 By Instruments 29
6.3.1 Imaging system 30
6.3.2 Ovum aspiration pumps 31
6.3.3 Sperm separation systems 31
6.3.4 Micromanipulator systems 31
6.3.5 Incubators 32
6.3.6 Cryosystems 32
6.3.7 Others 32
7 By Cycle type: Market Size and Analysis 33
7.1 Overview 33
7.2 Fresh IVF cycle (Non-Donor) 34
7.3 Thawed IVF cycle (Non-donor) 35
7.4 Donor egg IVF cycles 36
8 By End-Users: Market Size and Analysis 38
8.1 Overview 38
8.2 Hospitals and research laboratories 39
8.3 Fertility and surgical centers 39
8.4 Cryobanks 39
9 Regions: Market Size and Analysis 40
9.1 Overview 40
9.2 North America 41
9.3 Europe 43
9.4 Asia Pacific 44
9.5 Rest of the World 45
10 Competitive Landscape 47
10.1 Overview 47
11 Vendor Profiles 50
11.1 Thermo Fisher Scientific, Inc. 50
11.1.1 Overview 50
11.1.2 Business Units 54
11.1.3 Geographic Presence 55
11.1.4 Business focus 56
11.1.5 SWOT analysis 57
11.1.6 Business Strategy 57
11.2 Vitrolife 58
11.2.1 Overview 58
11.2.2 Geographic Presence 61
11.2.3 Business Focus 62
11.2.4 SWOT Analysis 63
11.2.5 Business Strategies 63
11.3 Cook Medical Inc. 64
11.3.1 Overview 64
11.3.2 Business Focus 66
11.3.3 SWOT Analysis 66
11.3.4 Business Strategies 66
11.4 Cooper Companies (CooperSurgical Inc.) 67
11.4.1 Overview 67
11.4.2 Business Unit 69
11.4.3 Geographic Presence 70
11.4.4 Business Focus 70
11.4.5 SWOT Analysis 71
11.4.6 Business Strategy 71
11.5 Irvine Scientific 72
11.5.1 Overview 72
11.5.2 Business Focus 74
11.5.3 SWOT Analysis 74
11.5.4 Business Strategy 75
12 Companies to Watch For 76
12.1 Genea Limited 76
12.1.1 Overview 76
12.2 EMD Sereno, Inc. 77
12.2.1 Overview 77
12.3 ESCO Micro Pte Ltd 78
12.3.1 Overview 78
12.3.2 ESCO Micro Pte Ltd: Recent Developments 79
12.4 Hunter Scientific 79
12.4.1 Overview 79
12.5 OvaScience Inc 80
12.5.1 Overview 80
12.5.2 OvaScience Inc: Recent Developments 80
12.6 Oxford Gene Technology 81
12.6.1 Overview 81
12.6.2 Oxford Gene Technology: Recent Developments 81
13 Annexure 82
13.1 Abbreviations 82

Read More

List of Tables


TABLE 1 GLOBAL IN VITRO FERTILIZATION MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION) 41
TABLE 2 OTHER PROMINENT VENDORS OF IN VITRO FERTILIZATION MARKET 48
TABLE 3 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 50
TABLE 4 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 51
TABLE 5 VITROLIFE: OFFERINGS 58
TABLE 6 VITROLIFE: RECENT DEVELOPMENTS 60
TABLE 7 COOK MEDICAL INC.: PRODUCT OFFERINGS 64
TABLE 8 COOK MEDICAL INC: RECENT DEVELOPMENTS 65
TABLE 9 COOPER COMPANIES (COOPERSURGICAL INC.): OFFERINGS 67
TABLE 10 COOPER COMPANIES (COOPERSURGICAL INC): RECENT DEVELOPMENTS 68
TABLE 11 IRVINE SCIENTIFIC: PRODUCT OFFERINGS 72
TABLE 12 IRVINE SCIENTIFIC: RECENT DEVELOPMENTS 74
TABLE 13 GENEA LIMITED: SNAPSHOT 76
TABLE 14 GENEA LIMITED: RECENT DEVELOPMENTS 76
TABLE 15 EMD SERENO, INC.: SNAPSHOT 77
TABLE 16 EMD SERENO, INC.: RECENT DEVELOPMENTS 77
TABLE 17 ESCO MICRO PTE LTD: SNAPSHOT 78
TABLE 18 HUNTER SCIENTIFIC: SNAPSHOT 79
TABLE 19 OVASCIENCE: SNAPSHOT 80
TABLE 20 OXFORD GENE TECHNOLOGY: SNAPSHOT 81

List of  Charts


CHART 1 RESEARCH METHODOLOGY OF GLOBAL IN VITRO FERTLIZATION MARKET 10
CHART 2 GLOBAL IN VITRO FERTILIZATION MARKET REVENUE, 2017–2024 ($MILLION) 14
CHART 3 SEGMENTATION OF GLOBAL IN VITRO FERTILIZATION MARKET 16
CHART 4 PEST ANALYSIS OF GLOBAL IN VITRO FERTILIZATION MARKET 17
CHART 5 PORTER 5 FORCES ON GLOBAL IN VITRO FERTILIZATION MARKET 18
CHART 6 DRO – IMPACT ANALYSIS OF GLOBAL IN VITRO FERTILIZATION MARKET 22
CHART 7 KEY STAKEHOLDERS 23
CHART 8 GLOBAL IN VITRO FERTILIZATION MARKET BY PRODUCT SEGMENTATION, 2017 (%) 25
CHART 9 GLOBAL IN VITRO FERTILIZATION MARKET BY PRODUCT SEGMENTATION, 2024 (%) 25
CHART 10 GLOBAL REAGENTS MARKET FORECAST, 2017–2024 ($MILLION) 26
CHART 11 GLOBAL REAGENTS MARKET SHARE, BY TYPE, 2017 (%) 27
CHART 12 GLOBAL INSTRUMENTS MARKET FORECAST, 2017–2024 ($MILLION) 29
CHART 13 GLOBAL INSTRUMENTS MARKET SHARE, BY TYPE, 2017 (%) 30
CHART 14 GLOBAL IN VITRO FERTILIZATION MARKET BY CYCLE TYPE SEGMENTATION, 2017 (%) 33
CHART 15 GLOBAL IN VITRO FERTILIZATION MARKET BY CYCLE TYPE SEGMENTATION, 2024 (%) 33
CHART 16 GLOBAL FRESH IVF CYCLE MARKET FORECAST, 2017–2024 ($MILLION) 34
CHART 17 GLOBAL THAWED IVF CYCLE MARKET FORECAST, 2017–2024 ($MILLION) 36
CHART 18 GLOBAL DONOR EGG IVF CYCLES MARKET FORECAST, 2017–2024 ($MILLION) 37
CHART 19 GLOBAL IN VITRO FERTILIZATION MARKET BY END USERS SEGMENTATION, 2017 (%) 38
CHART 20 GLOBAL IN VITRO FERTILIZATION MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 40
CHART 21 GLOBAL IN VITRO FERTILIZATION MARKET BY GEOGRAPHICAL SEGMENTATION, 2024 (%) 41
CHART 22 IN VITRO FERTILIZATION MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION) 42
CHART 23 IN VITRO FERTILIZATION MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION) 43
CHART 24 IN VITRO FERTILIZATION MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION) 45
CHART 25 IN VITRO FERTILIZATION MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION) 46
CHART 26 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT 54
CHART 27 THERMO FISHER SCIENTIFIC INC: BUSINESS UNITS 54
CHART 28 THERMO FISHER SCIENTIFIC, INC.: GEOGRAPHIC PRESENCE 55
CHART 29 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS 57
CHART 30 VITROLIFE: OVERVIEW SNAPSHOT 60
CHART 31 VITROLIFE: GEOGRAPHIC PRESENCE 61
CHART 32 : SWOT ANALYSIS 63
CHART 33 COOK MEDICAL INC.: SWOT ANALYSIS 66
CHART 34 COOPER COMPANIES (COOPERSURGICAL INC.): OVERVIEW SNAPSHOT 68
CHART 35 COOPER COMPANIES (COOPERSURGICAL INC.): BUSINESS UNITS 69
CHART 36 COOPER COMPANIES (COOPERSURGICAL INC.): GEOGRAPHIC PRESENCE 70
CHART 37 COOPER COMPANIES (COOPERSURGICAL INC.): SWOT ANALYSIS 71
CHART 38 IRVINE SCIENTIFIC: SWOT ANALYSIS 74

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$2750
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$3500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$4500
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Cervical Interbody Fusion Cages Market Research Report 2021
Global Cervical Interbody Fusion Cages Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-34M4136
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global In Vitro Fertilization Banking Service Market Size Status and Forecast 2021 2027
Global In Vitro Fertilization Banking Service Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-35S4143
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Vaginal Pessary Market Research Report 2021
Global Vaginal Pessary Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-31E4133
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Cryopreservation for In vitro Fertilization Market Size Status and Forecast 2021 2027
Global Cryopreservation for In-vitro Fertilization Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-34I4132
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0